Cargando…

The Tumor Necrosis Factor Superfamily of Cytokines in the Inflammatory Myopathies: Potential Targets for Therapy

The idiopathic inflammatory myopathies (IM) represent a heterogeneous group of autoimmune diseases, of which dermatomyositis (DM), polymyositis (PM), and sporadic inclusion body myositis (IBM) are the most common. The crucial role played by tumor necrosis factor alpha (TNFα) in the IM has long been...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Paepe, Boel, Creus, Kim K., De Bleecker, Jan L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202109/ https://www.ncbi.nlm.nih.gov/pubmed/22110532 http://dx.doi.org/10.1155/2012/369432

Ejemplares similares

Scanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory Myopathies
por: De Paepe, Boel, et al.
Publicado: (2015)

Incorporating circulating cytokines into the idiopathic inflammatory myopathy subclassification toolkit
por: De Paepe, Boel
Publicado: (2023)

Retrospective Study Shows That Serum Levels of Chemokine CXCL10 and Cytokine GDF15 Support a Diagnosis of Sporadic Inclusion Body Myositis and Immune-Mediated Necrotizing Myopathy
por: De Paepe, Boel, et al.
Publicado: (2023)

Cytokines and Chemokines as Regulators of Skeletal Muscle Inflammation: Presenting the Case of Duchenne Muscular Dystrophy
por: De Paepe, Boel, et al.
Publicado: (2013)

An exploratory study of circulating cytokines and chemokines in patients with muscle disorders proposes CD40L and CCL5 represent general disease markers while CXCL10 differentiates between patients with an autoimmune myositis
por: De Paepe, Boel, et al.
Publicado: (2022)

Anti-Inflammatory and General Glucocorticoid Physiology in Skeletal Muscles Affected by Duchenne Muscular Dystrophy: Exploration of Steroid-Sparing Agents
por: Herbelet, Sandrine, et al.
Publicado: (2020)

Targeting of the Tumor Necrosis Factor Receptor Superfamily for Cancer Immunotherapy
por: Bremer, Edwin
Publicado: (2013)

Abnormal NFAT5 Physiology in Duchenne Muscular Dystrophy Fibroblasts as a Putative Explanation for the Permanent Fibrosis Formation in Duchenne Muscular Dystrophy
por: Herbelet, Sandrine, et al.
Publicado: (2020)

Description of a Novel Mechanism Possibly Explaining the Antiproliferative Properties of Glucocorticoids in Duchenne Muscular Dystrophy Fibroblasts Based on Glucocorticoid Receptor GR and NFAT5
por: Herbelet, Sandrine, et al.
Publicado: (2020)

The Cytokine Growth Differentiation Factor-15 and Skeletal Muscle Health: Portrait of an Emerging Widely Applicable Disease Biomarker
por: De Paepe, Boel
Publicado: (2022)

Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily
por: Zaitseva, Olena, et al.
Publicado: (2023)

Role of Tumor Necrosis Factor Superfamily in Neuroinflammation and Autoimmunity
por: Sonar, Sandip, et al.
Publicado: (2015)

Localization and Expression of Nuclear Factor of Activated T-Cells 5 in Myoblasts Exposed to Pro-inflammatory Cytokines or Hyperosmolar Stress and in Biopsies from Myositis Patients
por: Herbelet, Sandrine, et al.
Publicado: (2018)

Tumour Necrosis Factor Superfamily Members in the Pathogenesis of Inflammatory Bowel Disease
por: Ślebioda, Tomasz J., et al.
Publicado: (2014)

Reverse Signaling of Tumor Necrosis Factor Superfamily Proteins in Macrophages and Microglia: Superfamily Portrait in the Neuroimmune Interface
por: Lee, Won-Ha, et al.
Publicado: (2019)

Myo-Inositol Transporter SLC5A3 Associates with Degenerative Changes and Inflammation in Sporadic Inclusion Body Myositis
por: De Paepe, Boel, et al.
Publicado: (2020)

Tetravalent biepitopic targeting enables intrinsic antibody agonism of tumor necrosis factor receptor superfamily members
por: Yang, Yanli, et al.
Publicado: (2019)

Tumor necrosis factor superfamily 14 is critical for the development of renal fibrosis
por: Li, You, et al.
Publicado: (2020)

Editorial: The Tumor Necrosis Factor Superfamily: An Increasing Role in Breast Cancer
por: Geerts, Dirk, et al.
Publicado: (2020)

Exploring the Therapeutic Potential of Ectoine in Duchenne Muscular Dystrophy: Comparison with Taurine, a Supplement with Known Beneficial Effects in the mdx Mouse
por: Merckx, Caroline, et al.
Publicado: (2022)

Induction of Osmolyte Pathways in Skeletal Muscle Inflammation: Novel Biomarkers for Myositis
por: De Paepe, Boel, et al.
Publicado: (2018)

Plasma Levels of Tumor Necrosis Factor Superfamily Molecules Are Increased in Bipolar Disorder
por: Barbosa, Izabela G., et al.
Publicado: (2017)

Tumor Necrosis Factor Superfamily: Ancestral Functions and Remodeling in Early Vertebrate Evolution
por: Marín, Ignacio
Publicado: (2020)

Description of Osmolyte Pathways in Maturing Mdx Mice Reveals Altered Levels of Taurine and Sodium/Myo-Inositol Co-Transporters
por: Merckx, Caroline, et al.
Publicado: (2022)

Up-Regulation of Tumor Necrosis Factor Superfamily Genes in Early Phases of Photoreceptor Degeneration
por: Genini, Sem, et al.
Publicado: (2013)

The Tumor Necrosis Factor Superfamily Molecule LIGHT Promotes Keratinocyte Activity and Skin Fibrosis
por: Herro, Rana, et al.
Publicado: (2015)

Tumor Necrosis Factor-Superfamily 15 Gene Expression in Patients with Sickle Cell Disease
por: Özçimen, Ahmet Ata, et al.
Publicado: (2014)

Differential Roles of Tumor Necrosis Factor Ligand Superfamily Members as Biomarkers in Pancreatic Cancer
por: Pombeiro, Ines, et al.
Publicado: (2018)

Receptor Oligomerization and Its Relevance for Signaling by Receptors of the Tumor Necrosis Factor Receptor Superfamily
por: Kucka, Kirstin, et al.
Publicado: (2021)

Expanding the TDP-43 Proteinopathy Pathway From Neurons to Muscle: Physiological and Pathophysiological Functions
por: Versluys, Lauren, et al.
Publicado: (2022)

Tumor necrosis family receptor superfamily member 9/tumor necrosis factor receptor-associated factor 1 pathway on hepatitis C viral persistence and natural history
por: Peña-Asensio, Julia, et al.
Publicado: (2020)

The Role of Taurine in Skeletal Muscle Functioning and Its Potential as a Supportive Treatment for Duchenne Muscular Dystrophy
por: Merckx, Caroline, et al.
Publicado: (2022)

A Critical Assessment of the Therapeutic Potential of Resveratrol Supplements for Treating Mitochondrial Disorders
por: De Paepe, Boel, et al.
Publicado: (2017)

Effects of bovine tumor necrosis factor alpha decoy receptors on cell death and inflammatory cytokine kinetics: potential for bovine inflammation therapy
por: Fujisawa, Sotaro, et al.
Publicado: (2019)

Interleukins, Chemokines, and Tumor Necrosis Factor Superfamily Ligands in the Pathogenesis of West Nile Virus Infection
por: Benzarti, Emna, et al.
Publicado: (2023)

Biological Therapies in Inflammatory Myopathies
por: Natour, Abd El Haleem, et al.
Publicado: (2023)

The Expression of Cytokine Profiles and Related Receptors in Idiopathic Inflammatory Myopathies
por: Zhou, Junyu, et al.
Publicado: (2022)

C-terminal frameshift variant of TDP-43 with pronounced aggregation-propensity causes rimmed vacuole myopathy but not ALS/FTD
por: Ervilha Pereira, Pedro, et al.
Publicado: (2023)

The inflammatory cytokine tumor necrosis factor modulates the expression of Salmonella typhimurium effector proteins
por: Ma, Jun, et al.
Publicado: (2010)

Tumor necrosis factor and interferon: cytokines in harmony
por: Bartee, Eric, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_dppnn242agsf4he3rj3oj6nkqm